Genomic DNA at disease-specific locus (gDNA)

Genomic DNA at a disease-specific locus refers to the precise chromosomal location where genetic variations or mutations directly contribute to a pathological state (Source: NIH Genetics Home Reference). As the primary repository of biological information, genomic DNA serves as the template for all cellular processes, including transcription and replication (Source: Nature Education). Mutations at specific loci, such as single nucleotide polymorphisms, deletions, or translocations, can lead to the expression of malformed proteins or the loss of essential regulatory control, driving diseases ranging from monogenic disorders like sickle cell anemia to complex malignancies (Source: PubMed, PMID: 30270435). Modern therapeutic modalities, particularly gene editing technologies like CRISPR-Cas9, Zinc Finger Nucleases, and base editors, are designed to interact directly with these loci to correct or disrupt the underlying genetic defect (Source: Science, DOI: 10.1126/science.1225829). By achieving site-specific modification, these therapies offer the potential for durable, often curative, clinical outcomes, as seen with the FDA-approved exagamglogene autotemcel (Source: FDA). However, the therapeutic use of genomic DNA as a target necessitates extreme precision to avoid off-target effects, which can result in unintended genomic instability or oncogenic transformations (Source: Nature Communications, DOI: 10.1038/s41467-018-04252-2).

Other names

Genomic DNAChromosomal DNATarget gene locusDNA sequenceGenetic locus

Site-specific genomic modification including gene disruption, correction, or insertion through DNA cleavage and endogenous repair mechanisms or direct chemical base modification (Source: Nature Reviews Drug Discovery).